Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,94 USD | +8,99% | -2,51% | -83,40% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 7,15 mln. 6,69 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -31 mln. -29,01 mln. | Nettowinst (verlies) 2025 * | -34 mln. -31,81 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 22 mln. 20,59 mln. | Nettoliquiditeiten 2025 * | 58 mln. 54,27 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-0,37
x | K/w-verhouding 2025 * |
-0,96
x | Werknemers | 14 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,06% |
Recentste transcriptie over eFFECTOR Therapeutics, Inc.
1 dag | +8,99% | ||
1 week | -2,51% | ||
Lopende maand | -86,52% | ||
1 maand | -84,27% | ||
3 maanden | -81,27% | ||
6 maanden | -86,14% | ||
Lopend jaar | -83,40% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Worland
CEO | Chief Executive Officer | 66 | 01-05-12 |
Michael Byrnes
DFI | Director of Finance/CFO | 47 | 01-12-20 |
Douglas Warner
CTO | Chief Tech/Sci/R&D Officer | 52 | 08-08-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Worland
CEO | Chief Executive Officer | 66 | 01-05-12 |
Director/Board Member | 54 | 25-08-21 | |
Caroline Loewy
BRD | Director/Board Member | 58 | 11-09-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 1,94 | +8,99% | 149 714 |
22-04-24 | 1,78 | +4,71% | 177 232 |
19-04-24 | 1,7 | -4,49% | 197 098 |
18-04-24 | 1,78 | -5,82% | 146 195 |
17-04-24 | 1,89 | -5,03% | 136 014 |
uitgestelde koers Nasdaq, 23 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-83,40% | 7,15 mln. | |
-0,49% | 105 mld. | |
+3,31% | 97,5 mld. | |
+2,82% | 22,19 mld. | |
-16,16% | 21,33 mld. | |
-7,42% | 18,68 mld. | |
-41,41% | 16,6 mld. | |
-22,87% | 14,52 mld. | |
+6,32% | 14,09 mld. | |
+21,46% | 10,99 mld. |